Brief: Lipocine Appoints Spyros Papapetropoulos As Lead Director And Chairman Of Board
03/11/2022 12:49
Nov 3 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE - SPYROS PAPAPETROPOULOS, HAS BEEN APPOINTED LEAD
DIRECTOR AND CHAIRMAN OF BOARD
Source text for Eikon: ID:nPn56mCcqa
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy